The Safety and Tolerability of WS016 in Healthy Chinese Volunteers

NCT06281470 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperkalemia

Interventions

DRUG: WS016 Single Dose(6g)
DRUG: WS016 Single Dose(12g)
DRUG: WS016 Single Dose(24g)
DRUG: WS016 Single Dose(36g)
DRUG: WS016 Single Dose(48g)
DRUG: SAD matching placebo
DRUG: WS016 Multiple Dose(12g)
DRUG: WS016 Multiple Dose(24g)
DRUG: WS016 Multiple Dose(48g)
DRUG: MAD matching placebo

Sponsor

Waterstone Pharmaceutical (Wuhan) Co., LTD.